Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bc9a207a305c5fc8a67253f17ccfd76c7> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bc9a207a305c5fc8a67253f17ccfd76c7 NCIT_P378 "NCI" @default.
- Bc9a207a305c5fc8a67253f17ccfd76c7 type Axiom @default.
- Bc9a207a305c5fc8a67253f17ccfd76c7 annotatedProperty IAO_0000115 @default.
- Bc9a207a305c5fc8a67253f17ccfd76c7 annotatedSource NCIT_C101259 @default.
- Bc9a207a305c5fc8a67253f17ccfd76c7 annotatedTarget "A pegylated, recombinant form of L-asparaginase derived from the bacterium Erwinia chrysanthemi (mPEG-R-Crisantaspase), with potential antineoplastic activity. Upon intravenous administration of pegylated recombinant L-asparaginase Erwinia chrysanthemi, asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting cancer cells of asparagine thus blocking protein synthesis and tumor cell proliferation. Asparagine is critical to protein synthesis in cancer cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. Compared to other available Erwinia chrysanthemi derived L-asparaginase agents, the pegylated form is longer acting and less immunogenic." @default.